Cargando…

Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells

Optogenetic assays provide a flexible, scalable, and information rich approach to probe compound effects for ion channel drug targets in both heterologous expression systems and associated disease relevant cell types. Despite the potential utility and growing adoption of optogenetics, there remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Borja, Gabriel B., Zhang, Hongkang, Harwood, Benjamin N., Jacques, Jane, Grooms, Jennifer, Chantre, Romina O., Zhang, Dawei, Barnett, Adam, Werley, Christopher A., Lu, Yang, Nagle, Steven F., McManus, Owen B., Dempsey, Graham T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289666/
https://www.ncbi.nlm.nih.gov/pubmed/35860501
http://dx.doi.org/10.3389/fnmol.2022.896320
_version_ 1784748718157725696
author Borja, Gabriel B.
Zhang, Hongkang
Harwood, Benjamin N.
Jacques, Jane
Grooms, Jennifer
Chantre, Romina O.
Zhang, Dawei
Barnett, Adam
Werley, Christopher A.
Lu, Yang
Nagle, Steven F.
McManus, Owen B.
Dempsey, Graham T.
author_facet Borja, Gabriel B.
Zhang, Hongkang
Harwood, Benjamin N.
Jacques, Jane
Grooms, Jennifer
Chantre, Romina O.
Zhang, Dawei
Barnett, Adam
Werley, Christopher A.
Lu, Yang
Nagle, Steven F.
McManus, Owen B.
Dempsey, Graham T.
author_sort Borja, Gabriel B.
collection PubMed
description Optogenetic assays provide a flexible, scalable, and information rich approach to probe compound effects for ion channel drug targets in both heterologous expression systems and associated disease relevant cell types. Despite the potential utility and growing adoption of optogenetics, there remains a critical need for compatible platform technologies with the speed, sensitivity, and throughput to enable their application to broader drug screening applications. To address this challenge, we developed the Swarm(TM), a custom designed optical instrument for highly parallelized, multicolor measurements in excitable cells, simultaneously recording changes in voltage and calcium activities at high temporal resolution under optical stimulation. The compact design featuring high power LEDs, large numerical aperture optics, and fast photodiode detection enables all-optical individual well readout of 24-wells simultaneously from multi-well plates while maintaining sufficient temporal resolution to probe millisecond response dynamics. The Swarm delivers variable intensity blue-light optogenetic stimulation to enable membrane depolarization and red or lime-light excitation to enable fluorescence detection of the resulting changes in membrane potential or calcium levels, respectively. The Swarm can screen ~10,000 wells/day in 384-well format, probing complex pharmacological interactions via a wide array of stimulation protocols. To evaluate the Swarm screening system, we optimized a series of heterologous optogenetic spiking HEK293 cell assays for several voltage-gated sodium channel subtypes including Nav1.2, Nav1.5, and Nav1.7. The Swarm was able to record pseudo-action potentials stably across all 24 objectives and provided pharmacological characterization of diverse sodium channel blockers. We performed a Nav1.7 screen of 200,000 small molecules in a 384-well plate format with all 560 plates reaching a Z′ > 0.5. As a demonstration of the versatility of the Swarm, we also developed an assay measuring cardiac action potential and calcium waveform properties simultaneously under paced conditions using human induced pluripotent stem (iPS) cell-derived cardiomyocytes as an additional counter screen for cardiac toxicity. In summary, the Swarm is a novel high-throughput all-optical system capable of collecting information-dense data from optogenetic assays in both heterologous and iPS cell-derived models, which can be leveraged to drive diverse therapeutic discovery programs for nervous system disorders and other disease areas involving excitable cells.
format Online
Article
Text
id pubmed-9289666
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92896662022-07-19 Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells Borja, Gabriel B. Zhang, Hongkang Harwood, Benjamin N. Jacques, Jane Grooms, Jennifer Chantre, Romina O. Zhang, Dawei Barnett, Adam Werley, Christopher A. Lu, Yang Nagle, Steven F. McManus, Owen B. Dempsey, Graham T. Front Mol Neurosci Molecular Neuroscience Optogenetic assays provide a flexible, scalable, and information rich approach to probe compound effects for ion channel drug targets in both heterologous expression systems and associated disease relevant cell types. Despite the potential utility and growing adoption of optogenetics, there remains a critical need for compatible platform technologies with the speed, sensitivity, and throughput to enable their application to broader drug screening applications. To address this challenge, we developed the Swarm(TM), a custom designed optical instrument for highly parallelized, multicolor measurements in excitable cells, simultaneously recording changes in voltage and calcium activities at high temporal resolution under optical stimulation. The compact design featuring high power LEDs, large numerical aperture optics, and fast photodiode detection enables all-optical individual well readout of 24-wells simultaneously from multi-well plates while maintaining sufficient temporal resolution to probe millisecond response dynamics. The Swarm delivers variable intensity blue-light optogenetic stimulation to enable membrane depolarization and red or lime-light excitation to enable fluorescence detection of the resulting changes in membrane potential or calcium levels, respectively. The Swarm can screen ~10,000 wells/day in 384-well format, probing complex pharmacological interactions via a wide array of stimulation protocols. To evaluate the Swarm screening system, we optimized a series of heterologous optogenetic spiking HEK293 cell assays for several voltage-gated sodium channel subtypes including Nav1.2, Nav1.5, and Nav1.7. The Swarm was able to record pseudo-action potentials stably across all 24 objectives and provided pharmacological characterization of diverse sodium channel blockers. We performed a Nav1.7 screen of 200,000 small molecules in a 384-well plate format with all 560 plates reaching a Z′ > 0.5. As a demonstration of the versatility of the Swarm, we also developed an assay measuring cardiac action potential and calcium waveform properties simultaneously under paced conditions using human induced pluripotent stem (iPS) cell-derived cardiomyocytes as an additional counter screen for cardiac toxicity. In summary, the Swarm is a novel high-throughput all-optical system capable of collecting information-dense data from optogenetic assays in both heterologous and iPS cell-derived models, which can be leveraged to drive diverse therapeutic discovery programs for nervous system disorders and other disease areas involving excitable cells. Frontiers Media S.A. 2022-07-04 /pmc/articles/PMC9289666/ /pubmed/35860501 http://dx.doi.org/10.3389/fnmol.2022.896320 Text en Copyright © 2022 Borja, Zhang, Harwood, Jacques, Grooms, Chantre, Zhang, Barnett, Werley, Lu, Nagle, McManus and Dempsey. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Neuroscience
Borja, Gabriel B.
Zhang, Hongkang
Harwood, Benjamin N.
Jacques, Jane
Grooms, Jennifer
Chantre, Romina O.
Zhang, Dawei
Barnett, Adam
Werley, Christopher A.
Lu, Yang
Nagle, Steven F.
McManus, Owen B.
Dempsey, Graham T.
Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells
title Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells
title_full Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells
title_fullStr Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells
title_full_unstemmed Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells
title_short Highly Parallelized, Multicolor Optogenetic Recordings of Cellular Activity for Therapeutic Discovery Applications in Ion Channels and Disease-Associated Excitable Cells
title_sort highly parallelized, multicolor optogenetic recordings of cellular activity for therapeutic discovery applications in ion channels and disease-associated excitable cells
topic Molecular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289666/
https://www.ncbi.nlm.nih.gov/pubmed/35860501
http://dx.doi.org/10.3389/fnmol.2022.896320
work_keys_str_mv AT borjagabrielb highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT zhanghongkang highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT harwoodbenjaminn highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT jacquesjane highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT groomsjennifer highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT chantrerominao highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT zhangdawei highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT barnettadam highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT werleychristophera highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT luyang highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT naglestevenf highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT mcmanusowenb highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells
AT dempseygrahamt highlyparallelizedmulticoloroptogeneticrecordingsofcellularactivityfortherapeuticdiscoveryapplicationsinionchannelsanddiseaseassociatedexcitablecells